EGFR and EGFRvIII signaling pathways
Description
Brief description about EGFR and EGFRvIII differences and signaling pathways
Acknowledgements
References
Nguyen, P.V.; Allard-Vannier, E.; Chourpa, I.; Hervé-Aubert, K. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design, and quality control. Int. J. Pharm. 2021, 605, 120795.
De Luca, A.; Carotenuto, A.; Rachiglio, A.; Gallo, M.; Maiello, M.R.; Aldinucci, D.; Pinto, A.; Normanno, N. The role of the EGFR signaling in tumor microenvironment. J. Cell. Physiol. 2008, 214, 559–567.
Sasaki, T.; Hiroki, K.; Yamashita, Y. The role of epidermal growth factor receptor in cancer metastasis and microenvironment. Biomed. Res. Int. 2013, 2013, 546318.
Grapa, C.M.; Mocan, T.; Gonciar, D.; Zdrehus, C.; Mosteanu, O.; Pop, T.; Mocan, L. Epidermal Growth Factor Receptor and its role in pancreatic cancer treatment mediated by nanoparticles. Int. J. Nanomed. 2019, 14, 9693–9706
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures